Pregled bibliografske jedinice broj: 700308
Paraoxonase 1 activity and phenotype distribution in premenopausal and postmenopausal women
Paraoxonase 1 activity and phenotype distribution in premenopausal and postmenopausal women // Biochemia Medica, 24 (2014), 2; 273-280 doi:10.11613/BM.2014.030 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 700308 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Paraoxonase 1 activity and phenotype distribution in premenopausal and postmenopausal women
Autori
Butorac, Dražan ; Ćelap, Ivana ; Kačkov, Sanja ; Robić, Vera ; Miletić, Tomislav ; Flegar- Meštrić, Zlata ; Hulina, Andrea ; Kuna, Krunoslav ; Žanić Grubišić, Tihana ; Grdić Rajković, Marija
Izvornik
Biochemia Medica (1330-0962) 24
(2014), 2;
273-280
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
paraoxonase 1 ; postmenopausal women ; phenotype ; lipids
Sažetak
Postmenopausal women have higher risk of cardiovascular disease. One of the contributing factors could be reduced activity of anti- atherogenic enzyme paraoxonase 1 (PON1). The aim of this study was to examine dierences in the lipid status, paraoxonase and arylesterase PON1 activities and PON1 phenotype in women with regular menstrual cycle and in postmenopausal women. The study included 51 women in reproductive age (25 in follicular and 26 in luteal phase of the menstrual cycle) and 23 women in postmenopause. Lipid parameters in sera were determined using original reagents and according to manufacturer protocol. PON1 activity in serum was assessed by spectrophotometric method with substrates: paraoxon and phenylacetate. PON1 phenotype was determined by double substrate method. Compared to the women in follicular and luteal phase, postmenopausal women have signi!cantly higher concentration of triglyceride [0.9 (0.7- 1.3), 0.7 (0.6-1.0) vs. 1.5 (0.9-1.7) mmol/L ; P = 0.002], cholesterol [5.10 (4.78-6.10), 5.05 (4.70-5.40) vs. 6.30 (5.73-7.23) mmol/L ; P < 0.001], LDL [3.00 (2.56- 3.63), 3.00 (2.70- 3.70) vs. 3.90 (3.23-4.50) mmol/L ; P < 0.001], and apolipoprotein B [0.88 (0.75-1.00), 0.79 (0.68- 1.00) vs. 1.07 (0.90- 1.24) mmol/L ; P = 0.002]. PON1 basal [104 (66- 260), 106 (63-250) vs. 93 (71-165) U/L ; P = 0.847] and salt- stimulated paraoxonase activity [210 (131- 462), 211 (120-442) vs. 180 (139-296) U/L ; P = 0.857] as well as arylesterase activity [74 (63- 82), 70 (54-91) vs. 70 (60-81) kU/L ; P = 0.906] and PON1 phenotype (P = 0.810) were not dierent in the study groups. There are no dierences in PON1 activity and PON1 phenotype between women with regular menstrual cycle and postmenopausal women.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Klinička bolnica "Merkur",
KBC "Sestre Milosrdnice"
Profili:
Ivana Ćelap
(autor)
Andrea Hulina Tomašković
(autor)
Dražan Butorac
(autor)
Marija Grdić Rajković
(autor)
Tihana Žanić-Grubišić
(autor)
Krunoslav Kuna
(autor)
Tomislav Miletić
(autor)
Zlata Flegar-Meštrić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- EMBASE (Excerpta Medica)
- EBSCO
- JCR
- ScienceCentral